Compare BZ & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZ | HIMS |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.0B |
| IPO Year | 2021 | 2019 |
| Metric | BZ | HIMS |
|---|---|---|
| Price | $13.48 | $28.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | $23.00 | ★ $30.46 |
| AVG Volume (30 Days) | 3.8M | ★ 18.2M |
| Earning Date | 05-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | $15.92 | $19.82 |
| Revenue Next Year | $12.78 | $19.23 |
| P/E Ratio | $22.61 | ★ N/A |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $12.85 | $13.74 |
| 52 Week High | $25.26 | $70.43 |
| Indicator | BZ | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 61.20 |
| Support Level | $13.02 | $28.94 |
| Resistance Level | $14.77 | $31.12 |
| Average True Range (ATR) | 0.59 | 1.93 |
| MACD | -0.02 | 0.33 |
| Stochastic Oscillator | 28.02 | 89.18 |
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.